Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | BMC Immunology

Fig. 3

From: Advanced in immunological monitoring of HIV infection: profile of immune cells and cytokines in people living with HIV-1 in Benin

Fig. 3

Frequencies of monocytes’ subpopulations in the study groups. The Fig. 3 shows the frequencies of total CD14+ monocytes (3A), classical (3B), intermediate (3C) and non-classical (3D) monocytes, in the control subjects (n=20), PLHIV-1 with therapeutic success (n=40) and PLHIV-1 with therapeutic failure (n=50) groups. Healthy control subjects and PLHIV-1 under ARV treatment for at least 6 months were recruited at the University hospital of Abomey-Calavi/Sô-Ava between October 2021 and April 2022. Data were shown as box plots representing medians (with 25th and 75th percentiles). The statistical differences were determined using the nonparametric Kruskal-Wallis test with Dunn’s multiple comparisons. Differences were considered significant when p values are less than 0.05

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us